Zepp Health Corp current report, Q2 FY2023

Zepp Health Corp Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, filed on April 24, 2023, is a supplemental submission pursuant to Item 16I(a) of Form 20-F. The filing addresses the Holding Foreign Companies Accountable Act (HFCAA) following the company's identification as a Commission-Identified Issuer in May 2022 due to its auditor, Deloitte Touche Tohmatsu Certified Public Accountants LLP, being headquartered in mainland China.

Key Financial Metrics

The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This document is strictly a regulatory compliance submission regarding corporate ownership structure and does not contain financial performance data.

Material Changes and Ownership Structure

The Company asserts it is not owned or controlled by a governmental entity of mainland China. As of February 28, 2023, the significant shareholders (holding 5% or more) and their voting power are as follows:

  • HHtech Holdings Limited: Beneficially owned 36.1% of total outstanding shares and 63.1% of aggregate voting power. Controlled by a trust for the benefit of Mr. Wang Huang and family.
  • People Better Limited: Beneficially owned 14.7% of total outstanding shares and 27.6% of aggregate voting power. A wholly-owned subsidiary of Xiaomi Corporation.
  • Allspring Entities: Beneficially owned 8.4% of total outstanding shares and 1.6% of aggregate voting power.
  • Shunwei High Tech Limited: Beneficially owned 6.8% of total outstanding shares and 1.3% of aggregate voting power. Controlled by Mr. Koh Tuck Lye.
  • FIL Limited: Beneficially owned 5.4% of total outstanding shares and 1.0% of aggregate voting power. Controlled by trusts for the benefit of the Johnson family.

The Company states it is not aware of any mainland Chinese governmental entity possessing the power to direct its management or policies.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or management commentary on business operations. The primary risk addressed is the potential delisting or regulatory action under the HFCAA due to the location of the auditor, which the Company mitigates by demonstrating a lack of Chinese government control.

Investor Verification Checklist

  • Verify the Company's status as a Commission-Identified Issuer under the HFCAA and the implications for continued listing on U.S. exchanges.
  • Confirm the independence of the Company from mainland Chinese governmental entities as claimed in this filing.
  • Review the most recent Form 20-F (filed April 24, 2023) for actual financial performance data, as this Form 6-K contains none.
  • Monitor the status of the PCAOB's ability to inspect the Company's auditor, Deloitte Touche Tohmatsu Certified Public Accountants LLP.